Comparison of microperc and mini-percutaneous nephrolithotomy for medium-sized lower calyx stones

The objective of this study was to present the outcomes of comparative clinical study of microperc versus mini-percutaneous nephrolithotomy (mini-PNL) in the treatment of lower calyx stones of 10–20 mm. Patients with lower calyx stones treated with microperc (Group-1) or mini-PNL (Group-2) between 2011 and 2014 were retrospectively analyzed. Demographics of the patients were compared, including age, gender, BMI, stone size, laterality and procedural parameters (operation and fluoroscopy time), and outcomes (success and complication rates). A total of 98 patients were evaluated, assigned to Group-1 (n = 58) and to Group-2 (n = 40). Groups were statistically similar in terms of age, stone size, and BMI (p = 0.3, 0.07, 0.6, respectively). The mean procedure and fluoroscopy duration for Group-1 were 43.02 ± 27.98 min and 112.05 ± 72.5 s, and 52.25 ± 23.09 min and 138.53 ± 56.39 s in Group-2 (p = 0.006 and 0.006). The mean hematocrit drop was significantly higher in Group-2 compared to Group-1 (3.98 vs. 1.96 %; p < 0.001); however, none of the cases required blood transfusion. Overall complication rates exhibited no statistically significant difference (p = 0.57). Stone-free status was similar (86.2 vs. 82.5 %, p = 0.66). The tubeless procedure rate was significantly higher in Group-1 (p < 0.001). In Group-2, duration of hospitalization was significantly longer than in Group-1 (2.63 vs. 1.55 days; p < 0.01). Outcomes of the present retrospective study show that microperc is a treatment option for medium-sized lower calyx stone, being associated with lower blood loss, procedure, reduced fluoroscopy and hospitalization time, and a higher tubeless rate. © 2015, Springer-Verlag Berlin Heidelberg.

Yazar Tok A.
Akbulut F.
Buldu I.
Karatag T.
Kucuktopcu O.
Gurbuz G.
Istanbulluoglu O.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/4818
Tek Biçim Adres 10.1007/s00240-015-0804-2
Konu Başlıkları Efficacy
Medium-size lower pole kidney stone
Micro-percutaneous nephrolithotomy
Mini-percutaneous nephrolithotomy
Safety
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı Urolithiasis
Dergi Cilt Bilgisi 44
Dergi Sayısı 2
Sayfalar 155 - 159
Yayın Yılı 2016
Eser Adı
[dc.title]
Comparison of microperc and mini-percutaneous nephrolithotomy for medium-sized lower calyx stones
Yazar
[dc.contributor.author]
Tok A.
Yazar
[dc.contributor.author]
Akbulut F.
Yazar
[dc.contributor.author]
Buldu I.
Yazar
[dc.contributor.author]
Karatag T.
Yazar
[dc.contributor.author]
Kucuktopcu O.
Yazar
[dc.contributor.author]
Gurbuz G.
Yazar
[dc.contributor.author]
Istanbulluoglu O.
Yayın Yılı
[dc.date.issued]
2016
Yayıncı
[dc.publisher]
Springer Verlag
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
The objective of this study was to present the outcomes of comparative clinical study of microperc versus mini-percutaneous nephrolithotomy (mini-PNL) in the treatment of lower calyx stones of 10–20 mm. Patients with lower calyx stones treated with microperc (Group-1) or mini-PNL (Group-2) between 2011 and 2014 were retrospectively analyzed. Demographics of the patients were compared, including age, gender, BMI, stone size, laterality and procedural parameters (operation and fluoroscopy time), and outcomes (success and complication rates). A total of 98 patients were evaluated, assigned to Group-1 (n = 58) and to Group-2 (n = 40). Groups were statistically similar in terms of age, stone size, and BMI (p = 0.3, 0.07, 0.6, respectively). The mean procedure and fluoroscopy duration for Group-1 were 43.02 ± 27.98 min and 112.05 ± 72.5 s, and 52.25 ± 23.09 min and 138.53 ± 56.39 s in Group-2 (p = 0.006 and 0.006). The mean hematocrit drop was significantly higher in Group-2 compared to Group-1 (3.98 vs. 1.96 %; p < 0.001); however, none of the cases required blood transfusion. Overall complication rates exhibited no statistically significant difference (p = 0.57). Stone-free status was similar (86.2 vs. 82.5 %, p = 0.66). The tubeless procedure rate was significantly higher in Group-1 (p < 0.001). In Group-2, duration of hospitalization was significantly longer than in Group-1 (2.63 vs. 1.55 days; p < 0.01). Outcomes of the present retrospective study show that microperc is a treatment option for medium-sized lower calyx stone, being associated with lower blood loss, procedure, reduced fluoroscopy and hospitalization time, and a higher tubeless rate. © 2015, Springer-Verlag Berlin Heidelberg.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Efficacy
Konu Başlıkları
[dc.subject]
Medium-size lower pole kidney stone
Konu Başlıkları
[dc.subject]
Micro-percutaneous nephrolithotomy
Konu Başlıkları
[dc.subject]
Mini-percutaneous nephrolithotomy
Konu Başlıkları
[dc.subject]
Safety
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
2194-7228
İlk Sayfa Sayısı
[dc.identifier.startpage]
155
Son Sayfa Sayısı
[dc.identifier.endpage]
159
Dergi Adı
[dc.relation.journal]
Urolithiasis
Dergi Sayısı
[dc.identifier.issue]
2
Dergi Cilt Bilgisi
[dc.identifier.volume]
44
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.1007/s00240-015-0804-2
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/4818
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
12
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
08 Şubat 2024 16:49
Google Kontrol
Tıklayınız
Group-1 Group-2 (p = 0 procedure fluoroscopy significantly microperc higher complication hospitalization statistically tubeless similar duration present treatment stones outcomes patients compared however comparative p = 0 status Stone-free significant difference (p  Overall transfusion clinical required exhibited including
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms